[{"id":"da69c7e7-102d-4aab-a50a-a190ae070b70","acronym":"","url":"https://clinicaltrials.gov/study/NCT01923298","created_at":"2021-01-18T08:40:55.972Z","updated_at":"2024-07-02T16:36:17.279Z","phase":"Phase 2","brief_title":"Estradiol Levels in Patients Treated With Estring","source_id_and_acronym":"NCT01923298","lead_sponsor":"University of Arizona","biomarkers":" ER","pipe":" | ","alterations":" ER positive","tags":["ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Estring (estradiol)"],"overall_status":"Completed","enrollment":" Enrollment 14","initiation":"Initiation: 08/09/2013","start_date":" 08/09/2013","primary_txt":" Primary completion: 06/30/2018","primary_completion_date":" 06/30/2018","study_txt":" Completion: 04/24/2019","study_completion_date":" 04/24/2019","last_update_posted":"2022-02-10"}]